Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity.

Abstract

Data on medical applications of cerium oxide nanoparticles CeO2 (CONP) are promising, yet information regarding their action in cells is incomplete and there are conflicting reports about in vitro toxicity. Herein, we have studied cytotoxic effect of CONP in several cancer and normal cell lines and their potential to change intracellular redox status. The IC50 was achieved only in two of eight tested cell lines, melanoma 518A2 and colorectal adenocarcinoma HT-29. Self-propagating room temperature method was applied to produce CONP with an average crystalline size of 4 nm. The results confirmed presence of Ce(3+) and O(2-) vacancies. The induction of cell death by CONP and the production of reactive oxygen species (ROS) were analyzed by flow-cytometry. Free radicals related antioxidant capacity of the cells was studied by the reduction of stable free radical TEMPONE using electron spin resonance spectroscopy. CONP showed low or moderate cytotoxicity in cancer cell lines: adenocarcinoma DLD1 and multi-drug resistant DLD1-TxR, non-small cell lung carcinoma NCI-H460 and multi-drug resistant NCI-H460/R, while normal cell lines (keratinocytes HaCaT, lung fetal fibroblasts MRC-5) were insensitive. The most sensitive were 518A2 melanoma and HT-29 colorectal adenocarcinoma cell lines, with the IC50 values being between 100 and 200 μM. Decreased rate of TEMPONE reduction and increased production of certain ROS species (peroxynitrite and hydrogen peroxide anion) indicates that free radical metabolism, thus redox status was changed, and antioxidant capacity damaged in the CONP treated 518A2 and HT-29 cells. In conclusion, changes in intracellular redox status induced by CONP are partly attributed to the prooxidant activity of the nanoparticles. Further, ROS induced cell damages might eventually lead to the cell death. However, low inhibitory potential of CONP in the other human cell lines tested indicates that CONP may be safe for human usage in industry and medicine.

• Authors: Milica Pešić, Ana Podolski-Renić, Sonja Stojković, Branko Matović, Danica Zmejkoski, Vesna Kojić, Gordana Bogdanović, Aleksandra Pavićević, Miloš Mojović, Aleksandar Savić, Ivana Milenković, Aleksandar Kalauzi, Ksenija Radotić
• Journal: Chemico-biological interactions (Chem Biol Interact) Vol. 232 Pg. 85-93 (May 05 2015) ISSN: 1872-7786 [Electronic] Ireland
• PMID: 25813935 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Chemical References

• Antineoplastic Agents
• Antioxidants
• Reactive Oxygen Species
• Triacetoneamine-N-Oxyl
• Cerium
• ceric oxide

Topics

• Antineoplastic Agents (pharmacology)
• Antioxidants (metabolism)
• Cell Line, Tumor (drug effects)
• Cerium (chemistry, pharmacology)
• Drug Screening Assays, Antitumor
• HT29 Cells (drug effects)
• Humans
• Nanoparticles (chemistry)
• Oxidation-Reduction
• Reactive Oxygen Species (metabolism)
• Triacetoneamine-N-Oxyl (metabolism, pharmacology)